A multi-cohort investigation of the effects of BDNF Val66Met on tau, neurodegeneration and cognition in preclinical Alzheimer’s disease

BDNF Val66Met 对临床前阿尔茨海默病中 tau、神经变性和认知影响的多队列研究

• 批准号: nhmrc : 1147465
• 金额: $ 21.72万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/multi-cohort-investigation-alzheimers-disease/1320853
• 关键词: multi; cohort; investigation; effects; BDNF

There are currently no disease modifying therapies for Alzheimer’s disease. We will elucidate the role of a genetic polymorphism that has previously been shown to exert neuroprotective effects on memory decline and brain volume loss associated with Alzheimer’s disease. By studying the role of this gene in multiple cohorts of individuals with varying degrees of Alzheimer’s disease risk, this study has high potential to uncover novel disease-modifying strategies for the treatment of the disease.

目前还没有针对阿尔茨海默病的疾病修饰疗法。我们将阐明先前已被证明对与阿尔茨海默病相关的记忆力下降和脑体积丧失起到神经保护作用的基因多态的作用。通过研究这种基因在具有不同程度阿尔茨海默病风险的多个人群中的作用，这项研究具有很高的潜力，可以发现治疗该疾病的新的疾病修改策略。